Announcement: Single protein discovery could unlock CAR-T cell therapy’s full potential

Last updated: 13/06/2026 08:51

0 Min Read

Researchers identify NFIL3 protein as key barrier to CAR-T cell therapy success. Disabling this protein maintained stronger cancer-fighting activity in preclinical models. — Photo: turek / Pexels

1 min read|39 words

🧬 Breakthrough discovery: Single protein NFIL3 identified as major barrier to CAR-T cell therapy success. When disabled, engineered immune cells maintained cancer-fighting power longer in preclinical studies. This could transform cancer immunotherapy durability.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Single protein discovery could unlock CAR-T cell therapy’s full potential →

Share This Article

ByProf. Giorgi Pkhakadze

Follow:

Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Announcement: Single protein discovery could unlock CAR-T cell therapy’s full potential

Submit Your Paper →

NHS workforce crisis threatens patient safety as early career doctors report severe burnout

GLP-1 Drugs Show 30% Lower Breast Cancer Risk in Major Study

Novel PET Tracer Detects Blood Clots in Legs and Lungs with Single Scan

Submit Your Paper to GMJ

Company

You Might Also Like